Study of the Life Stories of Patients Making a Request for Euthanasia, in the Context of Advanced Cancer. (RECIFE)

April 11, 2025 updated by: Centre Leon Berard
This study wishes to focus on the life course of patients, beyond the moments of suffering experienced at the time of the request for euthanasia. It is based on the perspective that the patient's account of his or her life course can be a source of information for better understanding and accompanying patients requesting euthanasia.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

7

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France, 69008
        • Centre Léon Bérard

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

We conduct our study in a French cancer center and a French public hospital. Patients requesting euthanasia will be informed about the possibility of participating in our study. If the patients agree, and if they meet the study criteria, they will be included.

Description

Inclusion Criteria:

  • Major patients
  • With cancer in the palliative phase, i.e. with an incurable disease according to current knowledge.
  • Expressing a request for euthanasia in terms evoking a request for death with the intervention of an outside person.
  • Non-opposition to the study after full written information.

Exclusion Criteria:

  • Severe decompensated psychiatric pathology
  • Vulnerable persons defined here as pregnant women, parturients and persons under legal protection or unable to express their consent
  • Inability to conduct an interview

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Description of the life stories of patients requesting euthanasia to explore which life experiences are brought forward when making this request, in a context of advanced oncological pathology.
Time Frame: One month

The main objective is to describe the life stories of patients requesting euthanasia in order to discover which life experiences are reasoning in the formulation of this request, in a context of advanced oncological pathology.

The investigators carry out a descriptive analysis of the interviews. The interviews will be analyzed as they are conducted, in order to identify themes of interest. The themes will be compared between the different interviews in order to identify possible trends.

One month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Calculation of the Bartholomew score
Time Frame: One month
Use of specific questionnaire (Relationship Scales Questionnaire of Batholomew) to describe the profiles of the patients in the study
One month
Calculation of the distress thermometer's score
Time Frame: One month
Use of specific questionnaire (NCCN distress thermometer) to describe the profiles of the patients in the study
One month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Actual)

July 31, 2024

Study Completion (Actual)

July 31, 2024

Study Registration Dates

First Submitted

May 9, 2023

First Submitted That Met QC Criteria

May 22, 2023

First Posted (Actual)

June 1, 2023

Study Record Updates

Last Update Posted (Actual)

April 16, 2025

Last Update Submitted That Met QC Criteria

April 11, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ET22000324

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe